You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 256 No. 20, November 28, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorials
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cholesterol Lowering and the Reduction of Coronary Heart Disease Risk

Basil M. Rifkind, MD; Claude Lenfant, MD

JAMA. 1986;256(20):2872-2873.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Cholesterol is an essential yet potentially dangerous molecule. As recently described by Brown and Goldstein1 in their Nobel Laureate lecture, the very property of cholesterol that makes it essential in cell membranes, namely, its absolute insolubility in water, also makes it potentially lethal. When it accumulates in the arterial wall it cannot be readily mobilized, and its presence eventually leads to the development of an atherosclerotic plaque and its sequelae. Brown and Goldstein also described the potential for errant cholesterol deposition to be aggravated by its dangerous tendency to exchange passively between blood lipoproteins and cell membranes. To transport cholesterol safely in the blood, its concentration must be kept sufficiently low and its tendency to escape from the bloodstream must be controlled.

The serious consequences of high cholesterol concentrations are readily apparent in familial hypercholesterolemia (FHC). Fortunately, its homozygous form is rare: one in 1 million in the population. . . . [Full Text PDF of this Article]


Author Affiliations

National Heart, Lung, and Blood Institute Bethesda, Md



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.